Estrogen receptor, progesterone receptor, and Her 2 Neu positivity and its association with tumour characteristics and menopausal status in a breast cancer cohort from northern Pakistan

ecancermedicalscience

Volumn 6, Issue 1, 2012, Pages

  Faheem, Mohammad ^a   Mahmood, Humera ^a   Khurram, Mohammad ^a   Qasim, Uzma ^a   Irfan, Javaid ^a  

^a PAKISTAN ATOMIC ENERGY COMMISSION   (Pakistan)

Author keywords

Estrogen receptor; Her 2 Neu oncogene; Overall survival; Postmenopausal; Progesterone receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER RECURRENCE; DISTANT METASTASIS; FEMALE; FREQUENCY ANALYSIS; GENE OVEREXPRESSION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; PAKISTAN; PREMENOPAUSE; SKIN METASTASIS; THORAX WALL CANCER; TUMOR VOLUME;

EID: 84872010402     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2012.283     Document Type: Article

References (25)

1. Burstein HJ, Harris JR and Morrow M (2008) Malignant tumors of the breast In Cancer Principles & Practice of Oncology, vol 2, ed VT Devita, TS Lawrence, SA Rosenberg. (Wolters Kluwer Lippincott: Williams and Wilkins) pp 1606-54
2. Bhurghuri Y (2004) Karachi cancer registry data implications for the national cancer control program of Pakistan Asian Pacific J Cancer Prev 5 77-82
3. Annual Report 2003-2004. Nuclear Medicine, Oncology and Radiotherapy Institute (NORI), Islamabad, 36 pp
4. Masood S (2000) Assessment of prognostic factors in breast fine-needle aspirates Am J Clin Pathol 113 (Suppl 1) S84-96
5. Sharif MA, Mamoon N, Arif A, Mushtaq S and Khadim MT (2009) Histological and immunohistochemical study of male breast carcinoma in Northern Pakistan JPMA 59 67-71
6. Maksimovic S (2009) Prognostic value HER-2/neu expression inT1 to T3 breast cancer with axillary lymph node metastasis Breast Cancer Res 11(Suppl 1) P9 DOI: 10.1186/bcr2292
7. Taneja P, Maglic D, Kai F, Zhu S, Kendig RD, Fry EA and Inoue K (2010) Classical and novel prognostic markers for breast cancer and their clinical significance Clin Med Insights Oncol 4 15-34 PMID: 20567632 PMCID: 2883240
8. Kariya S, Ogawa Y, Nishioka A, Moriki T, Ohnishi T, Ito S, Murata Y and Yoshida S (2005) Relationship between hormonal receptors, HER-2, p53 protein, bcl-2, and MIB-1 status and the antitumor effects of neoadjuvant anthracycline-based chemotherapy in invasive breast cancer patients Radiat Med 23(3) 189-94 PMID: 15940066
9. Kaptain S, Tan LK and Chen B (2001) Her-2/neu and breast cancer Diagn Mol Pathol 10 139-52 DOI: 10.1097/00019606-200109000-00001 PMID: 11552716
10. Almasri NM and Al Hamad M (2005) Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan Breast Cancer Res 7 R598-604 DOI: 10.1186/bcr1200 PMID: 16168103 PMCID: 1242123
11. Ayadi L, Khabir A, Amouri H, Karray S, Dammak A, Guermazi M et al (2008) Correlation of HER-2 over-expression with clinicopathological parameters in Tunisian breast carcinoma World Journal of Surgical Oncology 6 112-9 DOI: 10.1186/1477-7819-6-112 PMID: 18945339
12. Cianfrocca M and Goldstein LJ (2004) Prognostic and predictive factors in early stage breast cancer Oncologist 9(6) 606-16 DOI: 10.1634/theoncologist.9- 6-606 PMID: 15561805
13. Ferlay J, Bray F, Pisani P and Parkin DM (2004) Breast cancer. Cancer incidence, mortality and prevalence worldwide, vol 2, ed J Ferlay and DM Parkin (Lyon: IARC Press)
14. Abalkhail AA, Zahawi HM and Almasri NM (2003) The role of young population structure in determining age distribution of breast cancer in Jordan J Bahrain Med Soc 15 28-33
15. Cassol L, Graudenz MS, Zelmanowicz A, Cancela A, Werutsky G, Rvere RK et al Basal-like immunophenotype markers and prognosis in early breast cancer Tumori 96 966-70 PMID: 21388060
16. Farzami MR, Anjarani S, Safadel N, Amini R, Moghaddam MG, Roosta B et al Association between the expression of hormonal receptors, Her 2 Neu overexpression and tumor characteristics in Women with primary breast cancer Internet J Pathol 8(9)
17. Hussein MR, Abd-Elwahed SR and Abdulwahed AR (2008) Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of breast Cell Biol Int 32(6) 698-707 DOI: 10.1016/j.cellbi.2008.01.007 PMID: 18296077
18. Ambroise M, Ghosh M, Mallickarjuna VS and Kurian A (2011) Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India Asian Pac J Cancer Prev 12(3) 625-9 PMID: 21627355
19. Barlett JM, Ellis IO, Dowsett M, Cameron DA, Johnson S, Hall E et al (2007) Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER positive early stage breast cancer suitable for cytotoxic chemotherapy J Clin Oncol 25(28) 4423-30 DOI: 10.1200/JCO.2007.11.0973
20. Naeem M, Nasir A, Aman Z, Ahmad T and Samad A (2008) Frequency of Her 2 Neu receptor positivity and its association with other features of breast cancer J Ayub Med Coll Abbottabad 20(3) 23-6
21. Martinez SR, Young SE, Guiliano AE and Bilshik AJ (2006) The utility of estrogen receptor, progesterone receptor and Her 2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases Am J Surg 191(2) 281-3 DOI: 10.1016/j.amjsurg.2005.08.030 PMID: 16442961
22. Lower EE, Glass E, Blau R and Harman S (2009) Her 2/Neu expression in primary and metastatic breast cancer Breast Cancer Res Treat 113(2) 301-6 DOI: 10.1007/s10549-008-9931-6
23. Sharif MA, Mammon N, Mushtaq S and Khadim MT (2009) Morphological profile and association of Her 2/ Neu with prognostic markers in breast carcinoma in Northern Pakistan J Coll Physicians Surg Pak 19(2) 99-103 PMID: 19208313
24. Thor AD, Liu S, Edgerton S, Moore D 2nd, Kasowitz KM, Benz CC, Stern DF et al (2000) Activation (tyrosine phosphorylation) of ErbB2 (Her-2/neu): a study of incidence and correlation with outcome in breast cancer J Clin Oncol 18(18) 3230-9 PMID: 10986055
25. Azizun-Nisa, Bhurgri Y, Raza F, Kayani N (2008) Comparison of ER, PR and Her-2/neu (C-erbB2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer Asian Pac J Cancer Prev 9(4) 553-6